The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Subscription

18 Mar 2021 07:00

RNS Number : 6385S
Asimilar Group PLC
18 March 2021
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

 

18 March 2021

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Completion of Subscription

 

 

Further to the announcement of 1 March 2021, Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), notes the announcement today by Dev Clever Holdings plc ("Dev Clever") that it has published a prospectus dated 17 March 2021.

 

Accordingly the subscription by the Company's wholly owned subsidiary, Intrinsic Capital Jersey Limited ("ICJL"), for 30 million ordinary shares in Dev Clever at 10 pence per share will now proceed, with completion expected to occur on or around 23 March 2021 when the new ordinary shares in Dev Clever are admitted to trading.

 

On completion of the subscription, Asimilar will have an interest in 70 million ordinary shares in Dev Clever representing approximately 12.2 per cent. of Dev Clever's issued share capital. In addition to the 70 million ordinary shares, Asimilar retains a warrant to subscribe for 35 million new ordinary shares in Dev Clever at 25 pence per Dev Clever share.

 

Commenting on the completion of subscription, John Taylor, Non-Executive Chairman of Asimilar, said: "The successful completion of this subscription, with the share price of Dev Clever now trading at a significant premium to our entry price, demonstrates our ability to spot exciting opportunities and ensures we are able to benefit from their future growth.

 

"We remain excited by the future prospects of a number of our other investments and will update shareholders, as appropriate, in due course."

 

-ends-

 

 

For further information please contact:

 

 

 

 

Asimilar Group plc

 

 

John Taylor, Non-Executive Chairman

via Buchanan

 

 

 

 

Cairn Financial Advisers LLP

 

 

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

 

 

 

 

Peterhouse Capital Limited

 

 

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

 

 

 

 

Buchanan Communications Limited

 

 

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

     

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURFDLLFFXLEBBK
Date   Source Headline
18th Nov 20057:01 amRNSPositive Product Test Results
20th Oct 20057:00 amRNSTrading Statement
1st Aug 20059:27 amRNSBoard Appointment
29th Jul 20057:01 amRNSEgypt contract gain
8th Jul 200512:14 pmRNSResult of EGM
29th Jun 20055:30 pmRNSInterim Results
21st Jun 20057:00 amRNSOverseas Contract Gains
15th Jun 20054:03 pmRNSNotice of EGM
15th Jun 20052:21 pmRNSBoard Appointment
10th Jun 20057:00 amRNSOverseas Contract Gains
2nd Jun 20057:01 amRNSUS Collaboration deal
25th May 200512:30 pmRNSIssue of Equity
29th Mar 20051:13 pmRNSAGM Statement
2nd Feb 20054:51 pmRNSFinal Results Replacement
14th Jan 20051:39 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.